JSPR Stock Analysis: Buy, Sell, or Hold?
JSPR - Jasper Therapeutics, Inc. Common Stock
$0.70
-0.07 (-9.59%)
▼
5d:
+20.76%
30d:
+54.72%
90d:
-27.55%
WAIT
LOW Confidence
Analysis Updated: Jul 16, 2026 12:00 AM ET
Earnings: Aug 12, 2026
25d
Get Alerted When JSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: JSPR is 22.8% above its trading range ($0.57). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: JSPR is 22.8% above its trading range ($0.57). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: JSPR is currently trading at $0.70, which is considered extended relative to its 30-day fair value range of $0.41 to $0.57.
Technical Outlook: Technically, JSPR is in a strong downtrend. Immediate support is located at $0.42, while resistance sits at $0.81. Short-term momentum is weak, with the stock down 9.6% recently.
Market Sentiment: JSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.17 (+1224.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JSPR is in a strong downtrend. Immediate support is located at $0.42, while resistance sits at $0.81. Short-term momentum is weak, with the stock down 9.6% recently.
Market Sentiment: JSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.17 (+1224.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.41 -
$0.57
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+22.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.6%)
- BULLISH: Trading 1224.7% below Wall St target ($9.17)
- WARNING: Recommendation downgraded due to 22.8% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$0.81
Current Trend
Strong Downtrend
Technical data as of
Jul 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.27
Wall Street Target
$9.17
(+1224.7%)
Share & Embed Analysis
Last updated: July 17, 2026 11:07 AM ET
Data refreshes hourly during market hours. Next update: 12:07 PM
Data refreshes hourly during market hours. Next update: 12:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 56 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
